MED PHARMA SERVICE
MED PHARMA SERVICE, headquartered in Germany, is a prominent player in the pharmaceutical services industry, specialising in the development and distribution of high-quality medicinal products. Founded in 2005, the company has established a strong presence across Europe, particularly in Germany and surrounding regions. With a focus on innovative healthcare solutions, MED PHARMA SERVICE offers a diverse range of services, including pharmaceutical consulting, regulatory affairs, and logistics management. Their commitment to quality and compliance sets them apart in a competitive market, ensuring that clients receive tailored support that meets stringent industry standards. Recognised for their expertise and reliability, MED PHARMA SERVICE has achieved significant milestones, positioning themselves as a trusted partner for pharmaceutical companies seeking to enhance their operational efficiency and market reach.
DitchCarbon Score
How does MED PHARMA SERVICE's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MED PHARMA SERVICE's score of 0 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MED PHARMA SERVICE's reported carbon emissions
MED PHARMA SERVICE, headquartered in Germany, currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. Despite the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or initiatives related to carbon emissions. Additionally, there are no commitments to the Science Based Targets initiative (SBTi) or any climate pledges mentioned. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to set measurable targets for reducing their carbon footprint. As MED PHARMA SERVICE moves forward, establishing clear climate commitments and reduction strategies could enhance their environmental impact and align with industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MED PHARMA SERVICE is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
